Electron densities of bexarotene and disila-bexarotene from invariom application: a comparative study

By the application of the invariom formalism, which provides aspherical atomic scattering factors, the electron densities of the RXR-selective retinoid agonists bexarotene (1a) and disila-bexarotene (1b) were derived from their known low resolution (d = 0.76 Å) crystal structures. The density distri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Organic & biomolecular chemistry 2013-04, Vol.11 (14), p.2348-2354
Hauptverfasser: Luger, Peter, Weber, Manuela, Hübschle, Christian, Tacke, Reinhold
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:By the application of the invariom formalism, which provides aspherical atomic scattering factors, the electron densities of the RXR-selective retinoid agonists bexarotene (1a) and disila-bexarotene (1b) were derived from their known low resolution (d = 0.76 Å) crystal structures. The density distributions allowed us to make a comparison of the electronic properties of these pharmacologically relevant compounds. Differences were found to be restricted to relatively small regions in the terminal six-membered rings of the tetrahydronaphthalene and tetrahydrodisilanaphthalene fragments. In total, the replacement of two carbon atoms in 1a by silicon atoms (→1b) does neither influence the electronic structures nor the pharmacological properties (RXR receptor activation) significantly. It should be noted that the almost completely software supported invariom formalism can yield electronic information for biologically interacting systems with moderate effort. This offers interesting possibilities for drug research, in that steric and electronic information can be combined for the analysis of intermolecular recognition and interaction on an atomic scale. This approach is also valuable for the design and development of silicon-containing drugs using the carbon/silicon switch strategy.
ISSN:1477-0520
1477-0539
DOI:10.1039/c3ob27346f